The Antibody Cocktail, launched in India on Monday for treatment of mild to moderate COVID-19 in patients, is working against the disease, Dr Naresh Trehan said on Wednesday. One of the top doctors in the country, Trehan also said that the Antibody Cocktail, which is a combination of Casirivimab and Imdevimab, is effective against the B.1.617 variant of coronavirus, first …
Observing that no assurance was given by Roche India, which enjoys the license of manufacturing Tocilizumab 400 mg, if any further stock can be supplied to India, the Delhi High Court on Thursday sought Centre's response on the demand of the said drug and how does the Centre intend to obtain the supplies of the said drug through Roche India …
The Delhi High Court on Monday directed the Centre and the Delhi Government to take immediate steps to ensure that the Tocilizumab doses received by tonight and May 15 are allocated and distributed transparently in a timely and efficient manner to all States and Union Territories for administration of patients who are in dire need of the same. Moreover, the …
Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation from the Central Drugs Standards Control Organisation for Roche's investigational antibody cocktail used in the treatment of COVID-19. The approval of antibody cocktail of Casirivimab and Imdevimab in India was based on the data filed for the EUA in the US, and the scientific opinion of the …
Indian regulators have given emergency use authorization for an antibody-drug cocktail developed by Roche and Regeneron to treat COVID-19, Roche’s local partner said on Wednesday. The Central Drugs Standards Control Organisation gave Emergency Use Authorisation for its antibody cocktail Casirivimab and Imdevimab in India. The approval of antibody cocktail of Casirivimab and Imdevimab in India was based on the data …
)
)